Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 396,639,904
  • Shares Outstanding, K 2,682,900
  • Annual Sales, $ 76,450 M
  • Annual Income, $ 1,300 M
  • 36-Month Beta 0.59
  • Price/Sales 5.19
  • Price/Cash Flow 15.47
  • Price/Book 6.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.95
  • Number of Estimates 7
  • High Estimate 1.97
  • Low Estimate 1.93
  • Prior Year 1.74
  • Growth Rate Est. (year over year) +12.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
130.20 +2.15%
on 12/14/18
148.99 -10.73%
on 12/04/18
-11.25 (-7.80%)
since 11/14/18
3-Month
130.20 +2.15%
on 12/14/18
148.99 -10.73%
on 12/04/18
-6.49 (-4.65%)
since 09/14/18
52-Week
118.62 +12.12%
on 05/29/18
148.99 -10.73%
on 12/04/18
-8.65 (-6.11%)
since 12/14/17

Most Recent Stories

More News
Bragar Eagel & Squire, P.C. is Investigating Johnson & Johnson (JNJ) on Behalf of Stockholders and Encourages JNJ Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Johnson & Johnson (NYSE: JNJ). Our investigation concerns whether Johnson & Johnson has violated the federal securities laws and/or...

JNJ : 133.00 (-10.04%)
Stocks plunge to 8-month lows on growth fears; J&J nosedives

NEW YORK (AP) — Stocks staggered to eight-month lows Friday after weak economic data from China and Europe set off more worries about the global economy. Mounting tensions in Europe over Britain's impending...

SBUX : 65.34 (-2.35%)
JNJ : 133.00 (-10.04%)
ADBE : 230.00 (-7.29%)
AMGN : 192.07 (-2.76%)
PFE : 43.80 (-1.73%)
Hagens Berman Notifies Johnson & Johnson (JNJ) Investors of the Firm's Investigation of Possible Disclosure Violations

Hagens Berman Sobol Shapiro LLP notifies investors in Johnson & Johnson (NYSE: JNJ) of the Firm's investigation of possible disclosure violations. If you purchased or otherwise acquired JNJ shares between...

JNJ : 133.00 (-10.04%)
NOTICE TO CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the Johnson & Johnson Retirement Savings Plan for Possible ERISA Violations

Zamansky LLC announces that it has commenced an investigation of Johnson & Johnson Inc. (NYSE: JNJ) ("J&J") on behalf of its current and former employees over the J&J Retirement Savings Plan...

JNJ : 133.00 (-10.04%)
Johnson & Johnson, Adobe and Starbucks dip; Sealed Air rises

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:

ALK : 62.30 (+1.57%)
COST : 207.06 (-8.59%)
SEE : 33.94 (+4.75%)
SBUX : 65.34 (-2.35%)
JNJ : 133.00 (-10.04%)
SLB : 39.10 (-4.68%)
Markets Right Now: S&P 500 sinks to lowest level since April

NEW YORK (AP) — The latest on developments in financial markets (all times local):

JNJ : 133.00 (-10.04%)
ADBE : 230.00 (-7.29%)
Statement on Reuters Talc Article

Johnson & Johnson (NYSE: JNJ) today issued the following statement regarding speculation about the safety of our products.

JNJ : 133.00 (-10.04%)
INVESTOR ALERT: Ademi & O'Reilly, LLP Investigates Whether Johnson & Johnson (JNJ) Violated Securities Laws

Ademi & O'Reilly, LLP announces an investigation of Johnson & Johnson (NYSE: JNJ) for possible violations of securities laws.

JNJ : 133.00 (-10.04%)
Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO® (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) for XARELTO® (rivaroxaban) to the U.S. Food and Drug Administration...

JNJ : 133.00 (-10.04%)
5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019

The big drug stocks are on a strong footing of late. Here are five such picks from the biotech and large-cap pharma space that are expected to do well in 2019 too.

MRK : 76.48 (-3.20%)
JNJ : 133.00 (-10.04%)
LLY : 111.93 (-2.55%)
VRTX : 170.06 (-1.94%)
RHHBY : 31.0900 (-2.54%)
AMGN : 192.07 (-2.76%)
BIIB : 314.55 (-1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 151.37
1st Resistance Point 142.19
Last Price 133.00
1st Support Level 127.01
2nd Support Level 121.01

See More

52-Week High 148.99
Fibonacci 61.8% 137.39
Fibonacci 50% 133.81
Last Price 133.00
Fibonacci 38.2% 130.22
52-Week Low 118.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar